KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Change in Taxes (2019 - 2025)

Historic Change in Taxes for Ionis Pharmaceuticals (IONS) over the last 7 years, with Q3 2025 value amounting to $20000.0.

  • Ionis Pharmaceuticals' Change in Taxes rose 10823.05% to $20000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $60000.0, marking a year-over-year increase of 10019.34%. This contributed to the annual value of -$2.1 million for FY2024, which is 4834.07% up from last year.
  • According to the latest figures from Q3 2025, Ionis Pharmaceuticals' Change in Taxes is $20000.0, which was up 10823.05% from $26.0 million recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Change in Taxes ranged from a high of $26.0 million in Q2 2025 and a low of -$28.9 million during Q4 2023
  • Over the past 5 years, Ionis Pharmaceuticals' median Change in Taxes value was $2000.0 (recorded in 2021), while the average stood at -$11315.8.
  • Within the past 5 years, the most significant YoY rise in Ionis Pharmaceuticals' Change in Taxes was 31680000.0% (2023), while the steepest drop was 56396.6% (2023).
  • Over the past 5 years, Ionis Pharmaceuticals' Change in Taxes (Quarter) stood at -$414000.0 in 2021, then soared by 1605.56% to $6.2 million in 2022, then plummeted by 563.97% to -$28.9 million in 2023, then surged by 99.98% to -$7000.0 in 2024, then soared by 385.71% to $20000.0 in 2025.
  • Its last three reported values are $20000.0 in Q3 2025, $26.0 million for Q2 2025, and -$26.0 million during Q1 2025.